drugset / Trial / NCT01915173

Response to Supplement and Placebo in GERD

NCT01915173 ↗

Completed 24 enrolled Beth Israel Deaconess Medical Center
RandomizedFactorialQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the effects of a widely available over the counter supplement marketed for heartburn symptoms on symptoms and health-related quality of life in patients with gastroesophageal reflux disease (GERD). This study is designed as a pilot trial to assess safety and feasibility and to provide preliminary estimates of effect sizes.

Timeline

Start
2013-06
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Acidil Other / unclassified 2 unknown Intrathecal